The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer's disease

scientific article published on 28 August 2018

The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00259-018-4113-1
P698PubMed publication ID30155553

P50authorSusanna SchraenQ57699004
Xavier DelbeuckQ58876092
Alice JaillardQ91191511
Florence PasquierQ32424751
P2093author name stringAdeline Rollin-Sillaire
Stéphanie Bombois
Franck Semah
Aurélien Maureille
Matthieu Vanhoutte
Emilie Skrobala
P2860cites work18F-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer's diseaseQ47960333
Cerebrospinal fluid levels of amyloid beta-peptide1-42, but not tau have positive correlation with brain glucose metabolism in humansQ48095120
Frontotemporal behavioral scale.Q48314366
Functional correlates of t-Tau, p-Tau and Aβ₁₋₄₂ amyloid cerebrospinal fluid levels in Alzheimer's disease: a ¹⁸F-FDG PET/CT studyQ48346607
CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy studyQ48381623
Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET studyQ48387371
The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's diseaseQ48536651
Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF biomarkersQ50108175
Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.Q50764182
Exacerbated CSF abnormalities in younger patients with Alzheimer's disease.Q50913605
Mattis dementia rating scale: Internal reliability study using a diffusely impaired populationQ52100627
A new clinical scale for the staging of dementia.Q52220854
Longitudinal stability of CSF biomarkers in Alzheimer's disease.Q53286684
CSF biomarkers predict a more malignant outcome in Alzheimer disease.Q53309901
Neuropathological stageing of Alzheimer-related changesQ27860862
Cortical Surface-Based AnalysisQ28124697
Executive function and the frontal lobes: a meta-analytic reviewQ28248011
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseQ29547554
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeQ29614407
High-resolution intersubject averaging and a coordinate system for the cortical surfaceQ29615081
Smoothing and cluster thresholding for cortical surface-based group analysis of fMRI dataQ31063278
A disease-specific metabolic brain network associated with corticobasal degenerationQ34399253
Correction for partial volume effects in PET: principle and validationQ34468480
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's diseaseQ34526181
Neuropathology of variants of progressive supranuclear palsyQ34621283
Visuospatial function in early Alzheimer's disease--the use of the Visual Object and Space Perception (VOSP) batteryQ34848342
Visual association test to detect early dementia of the Alzheimer typeQ35468591
Nonamnestic presentations of early-onset Alzheimer's diseaseQ36763709
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's diseaseQ36912674
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Q37220632
Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings.Q37283742
Accurate and robust brain image alignment using boundary-based registrationQ37322859
Relationships between biomarkers in aging and dementiaQ37393992
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up studyQ40349700
Staging of Alzheimer's disease-related neurofibrillary changesQ40416705
The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's DiseaseQ42470207
Teaching NeuroImages: FDG-PET in progressive supranuclear palsyQ43109162
The meaning of cognitive impairment in the elderlyQ44556333
Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correctionQ44762713
Brain metabolic correlates of cerebrospinal fluid beta-amyloid 42 and tau in Alzheimer's disease.Q46013705
CSF biomarkers in relationship to cognitive profiles in Alzheimer diseaseQ46078133
Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's diseaseQ46121140
Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patientsQ46486075
An empirical comparison of surface-based and volume-based group studies in neuroimagingQ47578645
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.Q47589923
Low Prevalence and Clinical Effect of Vascular Risk Factors in Early-Onset Alzheimer's DiseaseQ47747859
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectbiomarkerQ864574
early-onset Alzheimer's diseaseQ5326566
P1104number of pages10
P304page(s)324-333
P577publication date2018-08-28
P1433published inEuropean Journal of Nuclear Medicine and Molecular ImagingQ15708890
P1476titleThe relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer's disease
P478volume46

Search more.